Gene expression experiments measure changes in RNA transcript levels to compare how genes are up- or down-regulated across different biological conditions and are a crucial element to many r ...

NEW YORK – Lex Diagnostics said on Monday that it has obtained 510 (k) clearance and CLIA waiver from the US Food and Drug Administration for its Velo point-of-care molecular diagnostic system and an ...

NINGBO, ZHEJIANG, CHINA, January 21, 2026 /EINPresswire.com/ -- Ningbo Scientz Biotechnology Co., Ltd., a leading ...

Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA analysis are the major factors which drive the global genotyping market ...

This Partnership Will Expand Verified Animal Disease Testing Solutions, Integrated with SecureDX's SecureOS™ AI Digital ...

Q4 2025 Management View Jonathan DiVincenzo, President & COO, stated that Bio-Rad delivered results within revised guidance ...

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

QIAGEN closed 2025 on a confident note, with management striking an upbeat tone despite acknowledging several short-term headwinds. The company beat its Q4 and full-year guidance on both sales and ...

Participants receive structured training in instrument setup, run execution, and robust data analysis methodologies.

These specialized fixed-income ETFs provide exposure to exotic areas of the bond market, but investors should be aware of ...

The global rapid microbiology testing market is experiencing significant growth, driven by the need for faster infection diagnosis and pharmaceutical quality control. The market is expanding due to ...